• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T1a和T1bN0M0期声门癌放疗的长期结果

Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.

作者信息

Nomiya Takuma, Nemoto Kenji, Wada Hitoshi, Takai Yoshihiro, Yamada Shogo

机构信息

Department of Radiation Oncology, Yamagata University School of Medicine, Yamagata, Japan.

出版信息

Laryngoscope. 2008 Aug;118(8):1417-21. doi: 10.1097/MLG.0b013e3181781791.

DOI:10.1097/MLG.0b013e3181781791
PMID:18528306
Abstract

OBJECTIVE/HYPOTHESIS: The purpose of this study is to determine the prognostic factors for local control and significance of total radiation dose in T1 glottic cancer.

STUDY DESIGN

Retrospective study.

METHODS

Data from 163 patients with T1 N0 M0 Stage I glottic squamous cell carcinoma (T1a: 115, T1b: 48) who were treated with radiotherapy alone during 1976 to 2002 were analyzed retrospectively. Age, source, total dose, field size, overall treatment time, and average fraction size were set as variables in multivariate analysis.

RESULTS

The 5-year local control rates (LCR) were 92.3% and 85.0% for patients with T1a and T1b glottic carcinoma, respectively. Only total radiation dose (P = .048) was a significant prognostic factor for local control in multivariate analysis of T1b glottic carcinoma. Local control in the higher total dose group was better than that in the lower total dose group (5 year LCRs were 100% and 76% for the group of > 66 Gy and the group of < or = 66 Gy, respectively. P = .024, logrank test). None of the treatment parameters were shown to be significant prognostic factors in multivariate analysis of T1a glottic carcinoma.

CONCLUSIONS

Radiotherapy with a total dose of 67 to 70 Gy seemed to be required for local control in T1b glottic carcinoma. No significant benefit of total radiation dose > 64 Gy was shown in the analysis of T1a glottic carcinoma.

摘要

目的/假设:本研究旨在确定T1期声门癌局部控制的预后因素及总辐射剂量的意义。

研究设计

回顾性研究。

方法

回顾性分析1976年至2002年间仅接受放射治疗的163例T1N0M0Ⅰ期声门鳞状细胞癌患者(T1a:115例,T1b:48例)的数据。将年龄、来源、总剂量、照射野大小、总治疗时间和平均分次剂量作为多因素分析的变量。

结果

T1a期和声门癌患者的5年局部控制率(LCR)分别为92.3%和85.0%。在T1b期声门癌的多因素分析中,仅总辐射剂量(P = 0.048)是局部控制的显著预后因素。总剂量较高组的局部控制优于总剂量较低组(> 66 Gy组和≤ 66 Gy组的5年LCR分别为100%和76%。P = 0.024,对数秩检验)。在T1a期声门癌的多因素分析中,没有治疗参数显示为显著的预后因素。

结论

T1b期声门癌局部控制似乎需要67至70 Gy的总剂量放疗。在T1a期声门癌分析中,未显示总辐射剂量> 64 Gy有显著益处。

相似文献

1
Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.T1a和T1bN0M0期声门癌放疗的长期结果
Laryngoscope. 2008 Aug;118(8):1417-21. doi: 10.1097/MLG.0b013e3181781791.
2
Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.早期声门癌伴前联合受累单纯放疗后局部控制率降低。
Strahlenther Onkol. 2004 Feb;180(2):84-90. doi: 10.1007/s00066-004-1164-y.
3
Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients.早期声门癌患者的放射治疗:一组连续入选的未筛选患者的单因素和多因素分析
Cancer. 2003 Aug 15;98(4):765-72. doi: 10.1002/cncr.11575.
4
Significance of pretreatment hemoglobin level in patients with T1 glottic cancer.T1期声门癌患者治疗前血红蛋白水平的意义
Radiat Oncol Investig. 1999;7(1):42-8. doi: 10.1002/(SICI)1520-6823(1999)7:1<42::AID-ROI6>3.0.CO;2-W.
5
Conservative treatment of early glottic carcinomas with exclusive radiotherapy.早期声门癌单纯放射治疗的保守治疗
Cancer Radiother. 2004 Oct;8(5):288-96. doi: 10.1016/j.canrad.2004.08.003.
6
[Radiotherapy in glottic T1 carcinoma. Local control and survival].[声门型T1期癌的放射治疗。局部控制与生存]
Acta Otorrinolaringol Esp. 2000 Jan-Feb;51(1):57-61.
7
T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy.声门型喉鳞状细胞癌 T1N0 至 T2N0,采用根治性放疗治疗。
Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):461-6. doi: 10.1016/j.ijrobp.2009.08.066. Epub 2010 Feb 12.
8
Management of stage IV glottic carcinoma: therapeutic outcomes.IV期声门癌的治疗:治疗结果
Laryngoscope. 2004 Aug;114(8):1438-46. doi: 10.1097/00005537-200408000-00024.
9
Hyperfractionated accelerated radiotherapy for T1,2 glottic carcinoma. Consideration of time-dose factors.T1、2期声门癌的超分割加速放疗。时间剂量因素的考量。
Strahlenther Onkol. 2008 Jul;184(7):364-9. doi: 10.1007/s00066-008-1819-1. Epub 2008 Oct 1.
10
Higher laryngeal preservation rate after CO2 laser surgery compared with radiotherapy in T1a glottic laryngeal carcinoma.与放射治疗相比,T1a期声门型喉癌二氧化碳激光手术后的喉保留率更高。
Head Neck. 2009 Jun;31(6):759-64. doi: 10.1002/hed.21027.

引用本文的文献

1
Pencil Beam Scanning Proton Therapy as Single Vocal Cord Irradiation for Early-Stage Glottic Cancer.笔形束扫描质子治疗作为早期声门癌单声带照射的治疗方法
Int J Part Ther. 2024 Jul 17;13:100623. doi: 10.1016/j.ijpt.2024.100623. eCollection 2024 Sep.
2
Nomogram for predicting survival in T1-T2 stage patients with supraglottic squamous cell carcinoma.预测声门上型鳞状细胞癌T1-T2期患者生存率的列线图。
Discov Oncol. 2024 May 8;15(1):147. doi: 10.1007/s12672-024-01015-y.
3
Daily fraction dose-adjusted radiotherapy policy to avoid prolonging the overall treatment time for early glottic squamous cell carcinoma: a single-institutional retrospective study.
每日分割剂量调整放疗策略以避免延长早期声门型鳞状细胞癌的总治疗时间:单机构回顾性研究。
J Radiat Res. 2024 Jan 19;65(1):63-70. doi: 10.1093/jrr/rrad080.
4
Intensity-Modulated Radiation Therapy for Early-Stage Squamous Cell Carcinoma of the Glottic Larynx: A Systematic Review and Meta-Analysis.强度调制放射治疗声门型早期喉鳞状细胞癌:系统评价和荟萃分析。
Int J Radiat Oncol Biol Phys. 2023 Nov 1;117(3):652-663. doi: 10.1016/j.ijrobp.2023.04.035. Epub 2023 May 6.
5
Usefulness of Semi-cylindrical Beam Spoiler in Treatment of Early Glottic Cancer Using 6 MV Photon Beam.半圆柱状射束挡块在 6MV 光子束治疗早期声门型喉癌中的应用价值
In Vivo. 2022 Jan-Feb;36(1):465-472. doi: 10.21873/invivo.12726.
6
Prognostic factors of patients with initially diagnosed T1a glottic cancer: Novel nomograms and a propensity-score matched cohort analysis.初诊为T1a期声门癌患者的预后因素:新型列线图与倾向评分匹配队列分析
Medicine (Baltimore). 2020 Nov 6;99(45):e23004. doi: 10.1097/MD.0000000000023004.
7
Therapeutic modalities and oncologic outcomes in the treatment of T1b glottic squamous cell carcinoma: a systematic review.T1b期声门型鳞状细胞癌治疗中的治疗方式与肿瘤学结局:一项系统评价
Eur Arch Otorhinolaryngol. 2017 Dec;274(12):4091-4102. doi: 10.1007/s00405-017-4736-z. Epub 2017 Sep 19.
8
Radiotherapy for laryngeal cancer-technical aspects and alternate fractionation.喉癌的放射治疗——技术层面与交替分割放疗
J Radiat Res. 2017 Jul 1;58(4):495-508. doi: 10.1093/jrr/rrx023.
9
Transoral laser microsurgery for T1b glottic cancer: review of 51 cases.经口激光显微手术治疗T1b期声门癌:51例病例回顾
Eur Arch Otorhinolaryngol. 2017 Apr;274(4):1997-2004. doi: 10.1007/s00405-016-4432-4. Epub 2016 Dec 27.
10
Short treatment time and excellent treatment outcome in accelerated hyperfractionated radiotherapy for T1 glottic cancer.T1期声门癌加速超分割放疗的治疗时间短且治疗效果优异。
Nagoya J Med Sci. 2015 Nov;77(4):585-94.